Clonidine-induced immune complex disease.
We report upon a 46-year-old woman, who developed immune complex disease after treatment with clonidine for one year. The diagnosis was verified with histological demonstration of IgG and IgM complexes as well as complement C1q, C3c and C4 between muscle fibres and at the dermo-epidermal junctions. The patient's symptoms abated and the abnormal results of blood tests reverted to normal following cessation of clonidine therapy.
Petersen
H H
HH
Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark.
Hansen
M
M
Albrectsen
J M
JM
D003000:Clonidine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007105:Immune Complex Diseases / Q000139:chemically induced* / Q000473:pathology; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008593:Menopause; D008875:Middle Aged
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003000:Clonidine